Eledon Pharmaceuticals, Inc. (ELDN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ELDN Revenue Growth
ELDN Revenue Analysis (2014–2025)
As of May 8, 2026, Eledon Pharmaceuticals, Inc. (ELDN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, ELDN's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including TGTX (+81.3% YoY), ACAD (+9.9% YoY), and NKTR (-43.9% YoY). Compare ELDN vs TGTX →
ELDN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ELDNCurrent | $0 | - | - | - | |
 TGTX | $616M | +81.3% | +426.7% | 20.0% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% |
ELDN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $0 | - |
| 2024 | $0 | - | $-359,000 | - | $-70,577,000 | - |
| 2023 | $0 | - | $-374,000 | - | $-43,000,000 | - |
| 2022 | $0 | - | $-373,000 | - | $-39,780,000 | - |
| 2021 | $0 | - | $-195,000 | - | $-36,867,000 | - |
| 2020 | $0 | - | $-183,000 | - | $-13,283,000 | - |
| 2019 | $0 | - | $-182,000 | - | $-14,184,000 | - |
| 2018 | $0 | - | $-11,000 | - | $-14,060,000 | - |
| 2017 | $0 | - | $-22,000 | - | $-13,121,000 | - |
| 2016 | $0 | - | $-35,000 | - | $-38,123,000 | - |
See ELDN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELDN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELDN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonELDN — Frequently Asked Questions
Quick answers to the most common questions about buying ELDN stock.
Is ELDN's revenue growth accelerating or slowing?
ELDN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ELDN's long-term revenue growth rate?
Eledon Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ELDN's revenue distributed by segment?
ELDN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.